Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease - 03/09/11
Doi : 10.1016/S0002-9149(01)01597-1
Andrew D Blann, PhD a, ⁎ 
, David Gurney, MSc a, Elizabeth Hughes, MD b, Peter Buggins, BSc b, Stanley H Silverman, MD c, Gregory Y.H Lip, MD a
, David Gurney, MSc a, Elizabeth Hughes, MD b, Peter Buggins, BSc b, Stanley H Silverman, MD c, Gregory Y.H Lip, MD a a Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom
b Department of Biochemistry, Sandwell General Hospital, Lyndon, West Bromwich, United Kingdom
c Department of Surgery, City Hospital, Birmingham, United Kingdom
*Dr. Blann’s address is: Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine. City Hospital, Birmingham B18 7QH, United Kingdom
 | This study was supported by a grant from Bristol-Myers Squibb, London, United Kingdom. |
© 2001
Excerpta Medica Inc. Tous droits réservés.
Vol 88 - N° 1
P. 89-92 - juillet 2001 Retour au numéro
Article précédent
- Late development of atrioventricular block after congenital heart surgery in down syndrome
- Mindy A Banks, Jennifer Jenson, John D Kugler
- Gradient and spin echo(cardiographic) magnetic resonance imaging: prevalence of descriptive errors in published articles
- Michael L Chuang, Warren J Manning, Pamela S Douglas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?